论文信息 - Preclinical Development Ganetespib , a Unique Triazolone-Containing Hsp 90 Inhibitor , Exhibits Potent Antitumor Activity and a Superior Safety Pro fi le for Cancer Therapy - 字舞流文

Preclinical Development Ganetespib , a Unique Triazolone-Containing Hsp 90 Inhibitor , Exhibits Potent Antitumor Activity and a Superior Safety Pro fi le for Cancer Therapy

D. Proia | K. Foley | R. Blackman | Lijun Sun | Jim Sang | J. Barsoum | S. Ye | Dan Zhou | W. Ying | L. S. Ogawa | Takayo Inoue | N. Tatsuta | Y. Wada | K. Koya | Zhen-Xian Du | J. Acquaviva | R. K. Blackman | Zhen‐Xian Du